Riskpilot← Back to searchSign inGet full accessDogan Medical AB
ABActiveOrg 5592920150Turebergs Allé 30General medical practice activities · NACE 8621Est. 20200 employees
Revenue 2024
—
EBITDA margin
—
-1% vs 2023
Equity ratio
88.4%
Financial strength
Net profit 2024
SEK -1K
-8% vs 2023
| Revenue | — | — |
| EBITDA | SEK -2K | -1% |
| Net profit | SEK -1K | -8% |
| Total assets | SEK 26K | -4% |
| Equity | SEK 23K | -5% |
| Employees | 0 | — |
Legal name
Dogan Medical AB
Org number
5592920150
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
18 december 2020
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Uthyrning av läkartjänster inom sluten- och primärvård. Utbildning, föreläsning och medicinsk rådgivning. Handel med finansiella instrument och därmed förenlig verksamhet.
Address
Turebergs Allé 30
Email
devran_90@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 0 | 0 | — | — |
| Staff expenses | — | −0 | — | — |
| EBITDA | — | — | −2 | −2 |
| Depreciation & amort. | −0 | — | — | — |
| EBIT | 0 | 0 | −2 | −2 |
| Net financials | — | — | 0 | 0 |
| Profit before tax | 0 | 0 | −1 | −1 |
| Tax | −0 | — | — | — |
| Net profit | 0 | 0 | −1 | −1 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 25 | 25 | 27 | 26 |
| Equity | 25 | 25 | 24 | 23 |
| Long-term debt | 0 | — | — | — |
| Short-term debt | 0 | — | 3 | 3 |
| Total debt | — | — | 3 | 3 |
EBITDA margin
-156000.0%
This company
15.8%
Market median
-987442% vs market
20212024
Equity ratio
88.4%
This company
38.2%
Market median
+131% vs market
20212024
Return on equity
-5.1%
This company
18.4%
Market median
-128% vs market
20212024
Net profit margin
-116200.0%
This company
8.1%
Market median
-1434668% vs market
20212024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212024
Debt / equity
0.13×
This company
0.62×
Market median
+79% vs market
20212024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-12-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
DD Chief Executive Officer | Chief Executive Officer | 2022 |
LD Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2022 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Dogan Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Devran Dogan | Chief Executive Officer | 0 companies |
| Lama Dogan | Deputy Chief Executive Officer | 0 companies |